Paul Tudor Jones Cure Vac N.V. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Cure Vac N.V. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 10,070 shares of CVAC stock, worth $35,647. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,070
Previous 12,282
18.01%
Holding current value
$35,647
Previous $51,000
41.18%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CVAC
# of Institutions
95Shares Held
15.3MCall Options Held
31.4KPut Options Held
137K-
Israel Englander Millennium Management LLC | New York, Ny2.76MShares$9.77 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.97MShares$6.99 Million0.0% of portfolio
-
Camber Capital Management LP Boston, MA1.75MShares$6.2 Million0.13% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.6MShares$5.66 Million5.88% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il981KShares$3.47 Million0.0% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $664M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...